After the cell viability data from all six CLL patients were analyzed together, we found that Nec-1 saved a smaller proportion of CLL cells from the effects of EA than did zVAD, indicating necroptosis contributed to a relatively small proportion of cell deaths induced by EA. The gene discussed is PCSK1; the disease is B-cell chronic lymphocytic leukemia.